NEXPOINT DIVERSIFIED REAL ESTATE TRUST — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that NEXPOINT DIVERSIFIED REAL ESTATE TRUST filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $85.97M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $83.22M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $63.28M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $55.13M | Mar 14, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($130.19M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($51.35M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($121.86M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($81.57M) | Mar 14, 2024 |
| FY2023 | Jun 30, 2022 | $126.83M | Mar 14, 2024 |
| FY2023 | Dec 31, 2021 | $245.46M | Mar 14, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.38M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($4.15M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $11.58M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $30.77M | Mar 14, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.17M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($11.67M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($24.27M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $31.43M | Mar 14, 2024 |
| FY2023 | Jun 30, 2022 | $36.34M | Mar 14, 2024 |
| FY2023 | Dec 31, 2021 | $38.07M | Mar 14, 2024 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.07B | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $1.22B | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $1.10B | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.22B | Mar 14, 2024 |
| FY2023 | Jul 1, 2022 | $1.31B | Mar 14, 2024 |
| FY2022 | Jun 30, 2022 | $1.14B | Mar 31, 2023 |
| FY2022 | Dec 31, 2021 | $1.05B | Mar 31, 2023 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $353.87M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $391.30M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $213.26M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $205.07M | Mar 14, 2024 |
| FY2023 | Jul 1, 2022 | $193.16M | Mar 14, 2024 |
| FY2022 | Jun 30, 2022 | $24.79M | Mar 31, 2023 |
| FY2022 | Dec 31, 2021 | $53.55M | Mar 31, 2023 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $700.09M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $836.51M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $885.07M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.02B | Mar 14, 2024 |
| FY2023 | Jul 1, 2022 | $1.11B | Mar 14, 2024 |
| FY2023 | Jun 30, 2022 | $1.11B | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $911.21M | Mar 31, 2023 |
| FY2022 | Dec 31, 2020 | $790.83M | Mar 31, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($362.08M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($202.82M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($126.58M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $17.95M | Mar 14, 2024 |
| FY2023 | Jul 1, 2022 | $112.98M | Mar 14, 2024 |
| FY2022 | Jun 30, 2022 | $112.98M | Mar 31, 2023 |
| FY2022 | Dec 31, 2021 | ($2.71M) | Mar 31, 2023 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.17M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $8.79M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $20.61M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $13.36M | Mar 14, 2024 |
| FY2023 | Jul 1, 2022 | $16.14M | Mar 14, 2024 |
| FY2022 | Jun 30, 2022 | $4.04M | Mar 31, 2023 |
| FY2022 | Dec 31, 2021 | $2.24M | Mar 31, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | (3) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | (2) | Mar 14, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | (3) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | (2) | Mar 14, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 50.13M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 42.68M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 38.39M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 37.17M | Mar 14, 2024 |
| FY2023 | Jul 1, 2022 | 37.17M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | 37.08M | Mar 31, 2023 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.01M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $4.94M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $13.41M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $11.15M | Mar 14, 2024 |